OPDIVO 10 mg/mL concentrate for solution for infusion., Relatlimab intravenous
IB 2019-03
Phase 2 small_molecule active
Quick answer
OPDIVO 10 mg/mL concentrate for solution for infusion., Relatlimab intravenous for Adult participants with advanced unresectable or metastatic soft-tissue sarcoma. is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Adult participants with advanced unresectable or metastatic soft-tissue sarcoma.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active